Conventionally Fractionated Re-irradiation for Recurrent Ependymoma

Clicks: 23
ID: 327455
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #98 of 287 articles by views in journal of neuro-oncology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 287 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Reirradiation is used for children and adolescents with recurrent ependymoma after prior surgery and focal irradiation. This study assessed the long-term benefits and risks of a second course of fractionated radiotherapy, patient selection, factors associated with progression-free survival (PFS) and overall survival (OS), and the role of craniospinal irradiation (CSI) at first recurrence. Methods From July 1994 to January 2024, 150 pediatric ependymoma patients at St. Jude Children’s Research Hospital received a second course of fractionated radiotherapy. Sixty-four were enrolled in a prospective trial. Inclusion required conventional fractionation (≥50.4Gy) for both courses, with CSI for metastatic disease. Kaplan-Meier estimates measured PFS and OS, Cox models assessed associations with covariates, and competing risks analysis evaluated necrosis and death from complications. Results At 10 and 20 years, PFS/OS for the cohort were 19.5%/34.3% and 9.0%/13.1%, respectively. Females had significantly better outcomes, and survival varied by initial failure pattern. No significant difference in PFS (p = 0.1351) or OS (p = 0.2705) was found between focal irradiation and CSI for patients with local failure. Necrosis was higher with proton therapy versus photons; grade 3 necrosis after reirradiation occurred in 19.9%. The 10-year cumulative incidence of death from complications or secondary tumors was 8.5%. Conclusions A second course of conventionally fractionated radiotherapy can extend survival in recurrent pediatric ependymoma, but prognosis remains poor, especially for those with combined local and distant failure or adverse features. CSI did not improve outcomes for local failures. Proton therapy increased necrosis risk, emphasizing the need for careful selection and follow-up.
Reference Key
openalex_W7207656304 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Thomas E Merchant, Hannah Worrall, Shengjie Wu, Yimei Li, Valerie J. Groben, Elizabeth Burghen, Haley M Ruleman, Kathryn Witt, Christina Bosley, Erika Krzeminski, Christopher L. Tinkle, Raja B. Khan, A. Gajjar, Kelsey C Bertrand, Asim Bag, Noah D. Sabin, Julie H. Harreld, David W Ellison, Frederick A. Boop, Paul Klimo
Are you one of these authors? Claim your profile
Journal journal of neuro-oncology
Year 2026
DOI
10.1093/neuonc/noag181
URL
https://doi.org/10.1093/neuonc/noag181
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.